Delivery Order SPE2DB24D2205-SPE2DB25FEFGS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a delivery order valued at $15,124.29 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) under a firm fixed-price contract type. This delivery order, which became effective on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a competitive award with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $29,812.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 29, 2025, with completion expected by September 30, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $5,520.01 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count supply) on September 16, 2025, with completion expected by September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,884.63 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 13, 2025, with completion scheduled for November 14, 2025. This non-competitive delivery order represents a firm fixed price transaction sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $18,492.01 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (quantity 8). This contract, with an ultimate completion date of September 4, 2025, represents a competitive award with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and operates as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,877.47 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen's role as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for NURTEC ODT 75 mg tablets in quantities of eight units, valued at $6,465.10. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion deadline of August 20, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 units) on April 24, 2025, with a ceiling value of $12,746.53. This competitive award, utilizing firm fixed pricing, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $39,616.92 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on November 4, 2025, with an ultimate completion date of November 5, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for the acute treatment...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFGSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) valued at $35,575.93 under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime contract enables AmerisourceBergen to supply pharmaceutical products and medical supplies globally to support military healthcare programs, serving customers including the Defense Health Agency and U.S. Coast Guard. NURTEC ODT is a migraine treatment medication, reflecting AmerisourceBergen's role as a critical vendor for specialty pharmaceuticals within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.6k | 7/23/25 |